The leading antibody discovery business in Boston, Abveris, offers contract research services to the biopharmaceutical sector. Abveris offers complete gene-to-antibody discovery services by combining cutting-edge immunisation techniques with B cell screening and hybridoma-based antibody-finding technology.
